Addus HomeCare Announces Third Quarter 2026 Financial Results
Addus HomeCare reported Q3 2026 net service revenues of $387.7M, up 7.0%, with net income of $28.6M ($1.54 per diluted share). Adjusted net income per share rose 17.3% YoY to $1.83. The company announced a deal to acquire AccentCare's personal care division for ~$100M. As of Q3 2026, cash on hand was $40.9M. Management highlighted strong growth in personal care and hospice segments. A conference call is scheduled for November 4, 2026.
How this was made
The 30-second read
Why it matters
The earnings release and acquisition announcement together provide fresh material for traders to reassess valuation and growth prospects.
Market read
First‑time Q3 2026 earnings and a strategic acquisition create a clear catalyst for ADUS, offering a medium‑term trading opportunity.
What to watch
Potential regulatory scrutiny of the acquisition and the company's reliance on Medicare reimbursement rates.
Background
Addus HomeCare is a NASDAQ‑listed provider of home‑care services. The company announced a strategic acquisition to expand its personal‑care footprint.
Ticker impact
Addus HomeCare reported Q3 2026 results with 7% revenue growth, $28.6M net income and announced a definitive agreement to acquire AccentCare's personal care division.
potential modest upside as investors price in revenue growth and acquisition synergies
First‑time disclosure of quarterly numbers and a material acquisition; market typically reacts positively to beat‑and‑buy signals.
Market effects
Home‑care and senior‑services sector may see increased investor interest due to Addus' growth and acquisition activity.
U.S. healthcare services market could experience modest buying pressure from the news.
Limited to U.S. healthcare equities; no broader macro impact.
Counterpoint
If integration costs of the AccentCare acquisition exceed expectations, the stock could face pressure despite earnings beat.
Key entities
- companyAddus HomeCare Inc.
NASDAQ: ADUS, provider of home‑care services.
- companyAccentCare
Target of Addus' personal‑care division acquisition.



